[go: up one dir, main page]

CN116326782A - Protein calcium and preparation method thereof - Google Patents

Protein calcium and preparation method thereof Download PDF

Info

Publication number
CN116326782A
CN116326782A CN202310334569.0A CN202310334569A CN116326782A CN 116326782 A CN116326782 A CN 116326782A CN 202310334569 A CN202310334569 A CN 202310334569A CN 116326782 A CN116326782 A CN 116326782A
Authority
CN
China
Prior art keywords
calcium
solution
protein
lactalbumin
citrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310334569.0A
Other languages
Chinese (zh)
Inventor
曹文慧
张营
李靖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Aurora Biotechnology Co ltd
Original Assignee
Nanjing Aurora Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Aurora Biotechnology Co ltd filed Critical Nanjing Aurora Biotechnology Co ltd
Priority to CN202310334569.0A priority Critical patent/CN116326782A/en
Publication of CN116326782A publication Critical patent/CN116326782A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

本发明公开了一种蛋白钙及其制备方法,将α‑乳白蛋白溶解,配制蛋白溶液;称取可溶性钙盐,配制钙溶液;蛋白液与钙溶液混合,搅拌,形成含有结合钙的蛋白钙溶液;称取柠檬酸钙,加入上述反应液,搅拌、超声,使柠檬酸钙分散更充分,形成混悬液;喷雾干燥,制备成粉。发明选择出一种既能够包裹住不溶性钙,又同时能与钙离子结合的蛋白,并且制作步骤相对简单,使得生产方案和产物能够落地;达到了提高产品含钙量,以及平缓钙的吸收利用的两方面的效果。

Figure 202310334569

The invention discloses protein calcium and a preparation method thereof. Alpha-lactalbumin is dissolved to prepare protein solution; soluble calcium salt is weighed to prepare calcium solution; protein solution and calcium solution are mixed and stirred to form protein calcium containing bound calcium solution; weighing calcium citrate, adding the above reaction solution, stirring and ultrasonication, so that the calcium citrate is more fully dispersed to form a suspension; spray-dried to prepare a powder. The invention selects a protein that can not only wrap insoluble calcium, but also combine with calcium ions, and the production steps are relatively simple, so that the production plan and products can be implemented; the calcium content of the product is increased, and the absorption and utilization of calcium is smooth two-sided effects.

Figure 202310334569

Description

一种蛋白钙及其制备方法A kind of calcium protein and preparation method thereof

技术领域technical field

本发明涉及一种蛋白钙及其制备方法,特别涉及蛋白结合钙与包埋游离钙The invention relates to protein calcium and its preparation method, in particular to protein-bound calcium and embedded free calcium

背景技术Background technique

钙的摄入情况对维持儿童/青少年正常骨密度、达到高骨量峰值、减少骨折和降低老年骨质疏松风险至关重要。现阶段由于人体中钙的缺乏,钙制剂的研究开发越来越受到人们的关注与重视。Calcium intake is critical for maintaining normal bone density in children/adolescents, achieving high peak bone mass, reducing fractures, and reducing the risk of osteoporosis in old age. Due to the lack of calcium in the human body at this stage, the research and development of calcium preparations has attracted more and more people's attention and attention.

现在补钙的同时增加蛋白质的摄入量会对骨组织生长起到正相关作用,但补钙的同时摄入充足的蛋白质才对骨骼有良好的改善效果。对于含钙量低的原料,若要摄入相同量的钙元素则需要更大剂量。At present, increasing protein intake while supplementing calcium will have a positive correlation effect on the growth of bone tissue, but sufficient protein intake while supplementing calcium will have a good effect on bone improvement. For raw materials with low calcium content, a larger dose is required to consume the same amount of calcium element.

中国发明申请专利(CN201510094700.6)公开的“一种基于难溶性钙和食源性蛋白复合物的新型钙增强剂及其制备和表征方法”,该法将食源性蛋白配制成溶液,难溶性钙分散在水中形成悬浮液,再按照蛋白和难溶性钙的质量比2:1~1:200混合,通过离心或静置将反应结束后的混合液分离,得到的沉淀漂洗、再分散,进行喷雾干燥或冷冻干燥处理,得到难溶性钙-蛋白复合粉末。该方法避免了额外添加稳定剂来稳定不溶性钙盐而造成的产品口感差和制备成本高等问题,但无法满足蛋白结合钙的高利用,高吸收;更无法达到钙源的逐步释放的效果。本发明的目的在于克服现有技术的不足,开发一种原料安全、性能稳定、含钙量高、吸收性能好、制备工艺简单的蛋白钙产品。Chinese invention application patent (CN201510094700.6) discloses "a new type of calcium enhancer based on insoluble calcium and food-derived protein complex and its preparation and characterization method". Calcium is dispersed in water to form a suspension, and then mixed according to the mass ratio of protein and insoluble calcium of 2:1 to 1:200, the mixed solution after the reaction is separated by centrifugation or standing, and the obtained precipitate is rinsed and redispersed. Spray-drying or freeze-drying treatment to obtain insoluble calcium-protein composite powder. This method avoids the problems of poor product taste and high preparation cost caused by adding additional stabilizers to stabilize insoluble calcium salts, but it cannot meet the high utilization and high absorption of protein-bound calcium; moreover, it cannot achieve the effect of gradual release of calcium sources. The purpose of the present invention is to overcome the deficiencies of the prior art and develop a calcium protein product with safe raw materials, stable performance, high calcium content, good absorption performance and simple preparation process.

发明内容Contents of the invention

本发明的目的在于针对现有技术的不足之处,提供一种蛋白钙的制备方法,(1)将α-乳白蛋白溶解,配制蛋白溶液;The object of the present invention is to provide a method for preparing calcium proteinate in view of the deficiencies of the prior art, (1) dissolving α-lactalbumin to prepare protein solution;

(2)称取可溶性钙盐,配制钙溶液;(2) Take by weighing soluble calcium salt, prepare calcium solution;

(3)蛋白液与钙溶液混合,搅拌,形成含有结合钙的蛋白钙溶液;(3) The protein solution is mixed with the calcium solution and stirred to form a protein-calcium solution containing bound calcium;

(4)称取柠檬酸钙,加入上述反应液,搅拌、超声,使柠檬酸钙分散更充分,形成混悬液;(4) take calcium citrate, add above-mentioned reaction solution, stir, ultrasonic, make calcium citrate disperse more fully, form suspension;

(5)喷雾干燥,制备成粉。(5) Spray drying and preparing into powder.

进一步的,α-乳白蛋白溶液的质量浓度为2~30%(w/w),进一步的8~12%(w/w),进一步的10%(w/w)。Further, the mass concentration of the α-lactalbumin solution is 2-30% (w/w), further 8-12% (w/w), further 10% (w/w).

进一步的,可溶性钙盐为氯化钙或乳酸钙,例如L-乳酸钙。Further, the soluble calcium salt is calcium chloride or calcium lactate, such as L-calcium lactate.

进一步的,钙溶液的质量浓度为0.1~5%,进一步的0.5~1.5%,进一步的1%。Further, the mass concentration of the calcium solution is 0.1-5%, further 0.5-1.5%, and further 1%.

进一步的,蛋白液与钙溶液混合质量比为(1-5):(5:1),进一步的1:1。Further, the mixing mass ratio of protein solution and calcium solution is (1-5):(5:1), further 1:1.

进一步的,蛋白液与钙溶液混合搅拌条件为0~35℃,优选为10~30℃,进一步优先为20~25℃。Further, the stirring condition of protein liquid and calcium solution is 0-35°C, preferably 10-30°C, more preferably 20-25°C.

进一步的,蛋白液与钙溶液混合搅拌0.5min-2h,例如30min。Further, the protein solution and the calcium solution are mixed and stirred for 0.5min-2h, for example, 30min.

进一步的,柠檬酸钙和反应液的超声时间为,2min以上,例如,5min,10min,20min。Further, the ultrasonication time of the calcium citrate and the reaction solution is more than 2 minutes, for example, 5 minutes, 10 minutes, 20 minutes.

进一步的,喷雾干燥条件:进风温度185~195℃,出风温度80~90℃,蠕动速度10~50rpm。Further, spray drying conditions: air inlet temperature 185-195°C, air outlet temperature 80-90°C, creep speed 10-50rpm.

本发明还提供了一种蛋白钙,采用上述的方法进行制备而成。The present invention also provides protein calcium, which is prepared by the above-mentioned method.

本发明还提供了一种蛋白钙,含有α-乳白蛋白和钙的结合物,以及由α-乳白蛋白包裹的不溶性钙。The present invention also provides protein calcium, which contains a combination of α-lactalbumin and calcium, and insoluble calcium wrapped by α-lactalbumin.

进一步的,α-乳白蛋白包裹的不溶性钙为柠檬酸钙和/或碳酸钙。Further, the insoluble calcium encapsulated by α-lactalbumin is calcium citrate and/or calcium carbonate.

有益效果:Beneficial effect:

(1)一方面,由于产品同时具有蛋白结合钙和包裹的柠檬酸钙,提高了产物的钙含量,另一方面,外层壳结合钙量少但吸收利用较快,而内部包裹的柠檬酸钙钙量大释放吸收利用较慢,使得钙的吸收利用方面更加的平缓。(1) On the one hand, because the product has protein-bound calcium and encapsulated calcium citrate at the same time, the calcium content of the product is increased; The large amount of calcium releases and absorbs slowly, making the absorption and utilization of calcium more gentle.

(2)本发明选择出一种既能够包裹住不溶性钙,又同时能与钙离子结合的蛋白,并且制作步骤相对简单,使得生产方案和产物能够落地;达到了提高产品含钙量,以及平缓钙的吸收利用的两方面的效果。(2) The present invention selects a protein that can not only wrap insoluble calcium, but also combine with calcium ions, and the production steps are relatively simple, so that the production plan and products can be implemented; The absorption and utilization of calcium have two effects.

(3)外部包裹的结合钙壳相对于柠檬酸钙混悬液稳定性和分散性更好,提高了吸收利用的效果。(3) Compared with the calcium citrate suspension, the externally bound calcium shell has better stability and dispersibility, which improves the effect of absorption and utilization.

术语解释Terminology Explanation

α-乳白蛋白,即α-LA,含有一个紧密结合的Ca2+,强烈地影响着稳定性和结构;一些α-乳白蛋白为糖蛋白,载运单个、典型的连接聚糖一些的α—乳白蛋白,有较高比例的糖基化分子,应当理解为α-乳白蛋白,以及α-乳白蛋白的衍生物,都是在本专利保护范围之内。α-lactalbumin, or α-LA, contains a tightly bound Ca 2+ that strongly affects stability and structure; some α-lactalbumins are glycoproteins, carrying a single, typically linked glycan Some α-lactalbumin Proteins, which have a relatively high proportion of glycosylated molecules, should be understood as α-lactalbumin and derivatives of α-lactalbumin, which are all within the protection scope of this patent.

附图说明Description of drawings

图1为蛋白钙的粒径情况;Fig. 1 is the particle size situation of protein calcium;

图2为扫描电镜微观结构;Figure 2 is the scanning electron microscope microstructure;

图3为复溶后,得物稳定性情况。Figure 3 shows the stability of the product after reconstitution.

具体实施方式Detailed ways

为了便于本领域技术人员的理解,下面结合实施例对本发明作进一步的说明,实施方式提及的内容并非对本发明的限定。In order to facilitate the understanding of those skilled in the art, the present invention will be further described below in conjunction with the examples, and the contents mentioned in the embodiments are not intended to limit the present invention.

实施例1Example 1

称取10g的α-LA,溶解在90g水中,配制质量浓度10%(w/w)的蛋白溶液,同时,配制0.6%(w/w)的氯化钙(二水)溶液,二者等质量混合,室温搅拌1h。再称取8g柠檬酸钙粉末加入上述混合液中,搅拌、超声5min形成混悬液,经喷雾干燥成粉,得到的蛋白钙粉末呈白色,D50=7.78±0.25μm,扫描电镜的微观结构清晰,柠檬酸钙基本被包裹完整,为夹心钙结构。将0.25g蛋白钙粉末复水形成的悬浮液(2.5%,w/w),在室温下静置1h后,结果显示蛋白钙的稳定性明显比柠檬酸钙好。Weigh 10g of α-LA, dissolve it in 90g of water, prepare a protein solution with a mass concentration of 10% (w/w), and at the same time, prepare a 0.6% (w/w) calcium chloride (dihydrate) solution, the two, etc. The mass was mixed and stirred at room temperature for 1h. Then weigh 8g of calcium citrate powder and add it to the above mixed solution, stir and ultrasonic for 5 minutes to form a suspension, which is spray-dried into powder, and the obtained calcium protein powder is white, D 50 =7.78±0.25μm, the microstructure of scanning electron microscope Clear, the calcium citrate is basically wrapped completely, and it is a sandwich calcium structure. The suspension (2.5%, w/w) formed by rehydrating 0.25g of calcium protein powder was left to stand at room temperature for 1 hour, and the results showed that the stability of calcium proteinate was significantly better than that of calcium citrate.

实施例2Example 2

称取10g的α-LA,溶解在90g水中,配制质量浓度10%(w/w)的蛋白溶液,同时,配制1.25%(w/w)的L-乳酸钙(五水)溶液(0.6%的氯化钙(二水)和1.25%的乳酸钙(五水),钙含量相同),二者等质量混合,室温搅拌1h。再称取8g柠檬酸钙粉末加入上述混合液中,搅拌、超声5min形成混悬液,经喷雾干燥成粉,得到的蛋白钙粉末呈白色,流动性好,D50=6.79±0.05μm,扫描电镜在激发电压5kV、放大10000倍观察到的粉末颗粒结构清晰(见图2中第三张图),柠檬酸钙被包裹完整,为夹心钙结构。将0.25g粉末复水形成的悬浮液(2.5%,w/w),在室温下静置1h后显示,基本不分层,稳定性优于柠檬酸钙。Weigh the α-LA of 10g, be dissolved in 90g water, prepare the protein solution of mass concentration 10% (w/w), meanwhile, prepare the L-calcium lactate (pentahydrate) solution (0.6% Calcium chloride (dihydrate) and 1.25% calcium lactate (pentahydrate, same calcium content), the two are mixed in equal mass, and stirred at room temperature for 1 hour. Then weigh 8g of calcium citrate powder and add it to the above mixture, stir and sonicate for 5 minutes to form a suspension, which is then spray-dried into powder. The calcium protein powder obtained is white and has good fluidity, D 50 =6.79±0.05μm, scan Electron microscopy at an excitation voltage of 5kV and a magnification of 10,000 times observed a clear powder particle structure (see the third picture in Figure 2), and the calcium citrate was completely wrapped, which was a sandwich calcium structure. The suspension (2.5%, w/w) formed by rehydrating 0.25 g of the powder showed basically no delamination after standing at room temperature for 1 h, and its stability was better than that of calcium citrate.

实施例3Example 3

称取10g的α-LA,溶解在90g水中,配制质量浓度10%(w/w)的蛋白溶液,同时,配制6%(w/w)的L-乳酸钙溶液,二者等质量混合,室温搅拌1h。再称取8g柠檬酸钙粉末加入上述混合液中,搅拌、超声5min形成混悬液,经喷雾干燥成粉,得到的蛋白钙粉末呈白色,D50=6.69±0.03μm,扫描电镜在激发电压5kV、放大10000倍观察到的粉末颗粒结构清晰(见图2第四张图),柠檬酸钙基本被包裹完整,为夹心钙结构。但颗粒不太完整,包裹效果不及实施例1和2。将0.25g粉末复水形成的悬浮液(2.5%,w/w),在室温下静置1h后有不明显分层。Weigh 10g of α-LA, dissolve it in 90g of water, prepare a protein solution with a mass concentration of 10% (w/w), and at the same time, prepare a 6% (w/w) L-calcium lactate solution, mix the two in equal mass, Stir at room temperature for 1 h. Then weigh 8g of calcium citrate powder and add it to the above mixed solution, stir and ultrasonic for 5min to form a suspension, and then spray-dry it into a powder. The powder particle structure observed at 5kV and 10,000 times magnification is clear (see the fourth picture in Figure 2), and the calcium citrate is basically completely wrapped, which is a sandwich calcium structure. But the particles are not complete, and the wrapping effect is not as good as that of Examples 1 and 2. The suspension (2.5%, w/w) formed by rehydrating 0.25 g of the powder had no obvious separation after standing at room temperature for 1 h.

实施例4Example 4

称取10g的α-LA,溶解在90g水中,配制质量浓度10%(w/w)的蛋白溶液,同时,配制1.25%(w/w)的L-乳酸钙溶液,二者等质量混合,室温搅拌1h。再称取12g柠檬酸钙粉末加入上述混合液中,搅拌、超声5min形成混悬液,经喷雾干燥成粉,得到的蛋白钙粉末呈白色,流动性好,D50=6.70±0.02μm,扫描电镜在激发电压5kV、放大10000倍观察到的粉末颗粒结构清晰(见图2第五张图),柠檬酸钙被包裹完整,为夹心钙结构。将0.25g粉末复水形成的悬浮液(2.5%,w/w),在室温下静置1h后无分层,稳定性较好,与实例2样品的“壳”相同,且含钙量较高。Weigh 10g of α-LA, dissolve it in 90g of water, prepare a protein solution with a mass concentration of 10% (w/w), and at the same time, prepare a 1.25% (w/w) L-calcium lactate solution, mix the two in equal mass, Stir at room temperature for 1 h. Then weigh 12g of calcium citrate powder and add it to the above mixture, stir and ultrasonic for 5min to form a suspension, and spray-dry to form a powder. The calcium protein powder obtained is white and has good fluidity. Electron microscope at an excitation voltage of 5kV and a magnification of 10,000 times observed a clear powder particle structure (see the fifth picture in Figure 2), and the calcium citrate was completely wrapped, which was a sandwich calcium structure. The suspension (2.5%, w/w) that 0.25g powder is rehydrated forms, after standing 1h at room temperature, there is no delamination, and the stability is better, the same as the "shell" of the example 2 sample, and the calcium content is higher high.

从图1可以看出,实施例1-4分别对应1-4,0为柠檬酸钙溶液混浊液相同条件下喷雾干燥的对照组。由D50可见,蛋白钙的粒径比柠檬酸钙溶液的粒径大很多;而蛋白钙之间的粒径存在差异,但差异并不大。As can be seen from Fig. 1, embodiments 1-4 correspond to 1-4 respectively, and 0 is the control group spray-dried under the same conditions of calcium citrate solution cloudy liquid. It can be seen from D 50 that the particle size of protein calcium is much larger than that of calcium citrate solution; and there are differences in particle size between protein calcium, but the difference is not large.

从图2可以看出,第一张图为柠檬酸钙溶液混浊液相同条件下喷雾干燥的对照组,实施例1-4分别对应图2中的第二到五张图。由图可知,蛋白钙粉末颗粒结构清晰,形成完整或者基本完整的壳儿,对柠檬酸钙能够起到包裹作用。As can be seen from Figure 2, the first picture is the control group spray-dried under the same conditions as the calcium citrate solution turbid liquid, and embodiments 1-4 correspond to the second to fifth pictures in Figure 2 respectively. It can be seen from the figure that the calcium protein powder has a clear particle structure and forms a complete or basically complete shell, which can wrap calcium citrate.

从图3可以看出,蛋白钙复溶后基本不分层或者有不明显的分层,而柠檬酸钙很快形成沉淀。It can be seen from Figure 3 that there is basically no or no obvious layering after reconstitution of calcium proteinate, while calcium citrate quickly forms a precipitate.

本技术领域技术人员可以理解,除非另外定义,这里使用的所有术语(包括技术术语和科学术语),具有与本发明所属领域中的普通技术人员的一般理解相同的意义。还应该理解的是,诸如通用字典中定义的那些术语,应该被理解为具有与现有技术的上下文中的意义一致的意义,并且除非像这里一样被特定定义,否则不会用理想化或过于正式的含义来解释。Those skilled in the art can understand that, unless otherwise defined, all terms (including technical terms and scientific terms) used herein have the same meaning as commonly understood by those of ordinary skill in the art to which this invention belongs. It should also be understood that terms, such as those defined in commonly used dictionaries, should be understood to have meanings consistent with their meaning in the context of the prior art, and unless specifically defined as herein, are not intended to be idealized or overly Formal meaning to explain.

应当理解,以上借助优选实施例对本发明的技术方案进行的详细说明是示意性的而非限制性的。本领域的普通技术人员在阅读本发明说明书的基础上可以对各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。It should be understood that the above detailed description of the technical solution of the present invention with the aid of preferred embodiments is illustrative rather than restrictive. Those skilled in the art can modify the technical solutions recorded in each embodiment on the basis of reading the description of the present invention, or perform equivalent replacements for some of the technical features; and these modifications or replacements do not make the corresponding technical solutions Essentially deviate from the spirit and scope of the technical solutions of the various embodiments of the present invention.

Claims (10)

1.一种蛋白钙的制备方法,其特征在于,(1)将α-乳白蛋白溶解,配制蛋白溶液;1. A preparation method of protein calcium, characterized in that, (1) alpha-lactalbumin is dissolved to prepare protein solution; (2)称取可溶性钙盐,配制钙溶液;(2) Take by weighing soluble calcium salt, prepare calcium solution; (3)蛋白液与钙溶液混合,搅拌,形成含有结合钙的蛋白钙溶液;(3) The protein solution is mixed with the calcium solution and stirred to form a protein-calcium solution containing bound calcium; (4)称取柠檬酸钙,加入上述反应液,搅拌、超声,使柠檬酸钙分散更充分,形成混悬液;(4) take calcium citrate, add above-mentioned reaction solution, stir, ultrasonic, make calcium citrate disperse more fully, form suspension; (5)喷雾干燥,制备成粉。(5) Spray drying and preparing into powder. 2.如权利要求1所述的方法,其特征在于,α-乳白蛋白溶液的质量浓度为2~30%(w/w),进一步的8~12%(w/w),进一步的10%(w/w)。2. The method according to claim 1, wherein the mass concentration of the α-lactalbumin solution is 2 to 30% (w/w), further 8 to 12% (w/w), and further 10% (w/w). 3.如权利要求1所述的方法,其特征在于,可溶性钙盐为氯化钙或乳酸钙,例如L-乳酸钙。3. The method of claim 1, wherein the soluble calcium salt is calcium chloride or calcium lactate, such as calcium L-lactate. 4.如权利要求1所述的方法,其特征在于,钙溶液的质量浓度为0.1-5%,进一步的0.5~1.5%,进一步的1%。4. The method according to claim 1, characterized in that the mass concentration of the calcium solution is 0.1-5%, further 0.5-1.5%, further 1%. 5.如权利要求1所述的方法,其特征在于,蛋白液与钙溶液混合质量比为(1-5):(5:1),进一步的1:1。5. The method according to claim 1, characterized in that the mixing mass ratio of protein solution and calcium solution is (1-5):(5:1), further 1:1. 6.如权利要求1所述的方法,其特征在于,蛋白液与钙溶液混合搅拌条件为0~35℃,优选为10~30℃,进一步优先为20~25℃。6. The method according to claim 1, characterized in that the stirring condition of protein solution and calcium solution is 0-35°C, preferably 10-30°C, more preferably 20-25°C. 7.如权利要求1所述的方法,其特征在于,蛋白液与钙溶液混合搅拌0.5min-2h,例如30min;7. The method according to claim 1, wherein the protein solution and the calcium solution are mixed and stirred for 0.5min-2h, for example 30min; 和/或and / or 进一步的,柠檬酸钙和反应液的超声时间为,2min以上,例如,5min,10min,20min;Further, the ultrasonic time of calcium citrate and the reaction solution is more than 2 minutes, for example, 5 minutes, 10 minutes, 20 minutes; 和/或and / or 喷雾干燥条件:进风温度185~195℃,出风温度80~90℃,蠕动速度10~50rpm。Spray drying conditions: air inlet temperature 185~195℃, outlet air temperature 80~90℃, creep speed 10~50rpm. 8.一种蛋白钙,其特征在于,采用权利要求1-7之一的方法进行制备而成。8. A calcium protein, characterized in that it is prepared by the method of any one of claims 1-7. 9.一种蛋白钙,其特征在于,含有α-乳白蛋白和钙的结合物,以及由α-乳白蛋白包裹的不溶性钙。9. A calcium protein, characterized by comprising a conjugate of α-lactalbumin and calcium, and insoluble calcium encapsulated by α-lactalbumin. 10.如权利要求9所述的蛋白钙,其特征在于,α-乳白蛋白包裹的不溶性钙为柠檬酸钙和/或碳酸钙。10. The protein calcium according to claim 9, characterized in that the insoluble calcium encapsulated by α-lactalbumin is calcium citrate and/or calcium carbonate.
CN202310334569.0A 2023-03-31 2023-03-31 Protein calcium and preparation method thereof Pending CN116326782A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310334569.0A CN116326782A (en) 2023-03-31 2023-03-31 Protein calcium and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310334569.0A CN116326782A (en) 2023-03-31 2023-03-31 Protein calcium and preparation method thereof

Publications (1)

Publication Number Publication Date
CN116326782A true CN116326782A (en) 2023-06-27

Family

ID=86877066

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310334569.0A Pending CN116326782A (en) 2023-03-31 2023-03-31 Protein calcium and preparation method thereof

Country Status (1)

Country Link
CN (1) CN116326782A (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766330A (en) * 1996-12-24 1998-06-16 Knights; Ralph J. Method of suspending insoluble calcium in protein composition
WO2000045650A1 (en) * 1999-02-06 2000-08-10 Nutrahealth Ltd. (Uk) Calcium supplemented food products and novel calcium-containing ingredient
CN104738649A (en) * 2015-03-03 2015-07-01 江南大学 Novel calcium enhancer based on poorly-soluble calcium and food-borne protein complexes as well as preparation method and characterization method thereof
CN106343579A (en) * 2016-08-30 2017-01-25 雷春生 Fish bladder collagen small peptide chelate calcium and preparing method thereof
CN107549801A (en) * 2017-08-24 2018-01-09 福格森(武汉)生物科技股份有限公司 A kind of multilayer embeds solid lipid calcium particulate
CN110604213A (en) * 2019-09-09 2019-12-24 苏州恒瑞健康科技有限公司 Process method for improving protein stability
CN113813362A (en) * 2021-09-27 2021-12-21 山东安为先生物科技有限公司 Stable small peptide chelated calcium, preparation method and application
CN114401639A (en) * 2019-09-16 2022-04-26 雀巢产品有限公司 Whey-based nutritional composition fortified with calcium
US20220386674A1 (en) * 2019-11-13 2022-12-08 Societe Des Produits Nestle S.A. Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766330A (en) * 1996-12-24 1998-06-16 Knights; Ralph J. Method of suspending insoluble calcium in protein composition
WO2000045650A1 (en) * 1999-02-06 2000-08-10 Nutrahealth Ltd. (Uk) Calcium supplemented food products and novel calcium-containing ingredient
CN104738649A (en) * 2015-03-03 2015-07-01 江南大学 Novel calcium enhancer based on poorly-soluble calcium and food-borne protein complexes as well as preparation method and characterization method thereof
CN106343579A (en) * 2016-08-30 2017-01-25 雷春生 Fish bladder collagen small peptide chelate calcium and preparing method thereof
CN107549801A (en) * 2017-08-24 2018-01-09 福格森(武汉)生物科技股份有限公司 A kind of multilayer embeds solid lipid calcium particulate
CN110604213A (en) * 2019-09-09 2019-12-24 苏州恒瑞健康科技有限公司 Process method for improving protein stability
CN114401639A (en) * 2019-09-16 2022-04-26 雀巢产品有限公司 Whey-based nutritional composition fortified with calcium
US20220378064A1 (en) * 2019-09-16 2022-12-01 Societe Des Produits Nestle S.A. Whey-based nutritional compositions fortified with calcium
US20220386674A1 (en) * 2019-11-13 2022-12-08 Societe Des Produits Nestle S.A. Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol
CN113813362A (en) * 2021-09-27 2021-12-21 山东安为先生物科技有限公司 Stable small peptide chelated calcium, preparation method and application

Similar Documents

Publication Publication Date Title
CN112042937B (en) Water-soluble lutein emulsion gel and preparation method thereof
CN105054073B (en) A kind of water miscible vitamine D3 nano particle and preparation method thereof
CN110679953A (en) Preparation method of nano liposome embedded with egg white source active peptide
CN108484715A (en) A kind of protein binding type nanometer selenium and its preparation method and application
CN107496359A (en) The preparation method of PluronicF127 curcumin liposomes
CN110367410A (en) A kind of compound lactobacillus fruit drink and preparation method thereof
CN116326782A (en) Protein calcium and preparation method thereof
KR100871050B1 (en) Preparation method of microcapsules containing coenzyme q-ten
CN114651989A (en) Donkey-hide gelatin peptide-iron chelate microcapsule and preparation method thereof
CN113875979A (en) A kind of preparation method of food-grade oil-water dual-phase loaded emulsion gel carrier system
CN117099849A (en) Pure goat milk protein formula goat milk powder and preparation method thereof
CN115886255B (en) A high-stability blueberry anthocyanin binary gel tablet and preparation method thereof
AU2021103800A4 (en) Controlled-Released Lutein Emulsion Gel and Formulation Thereof
CN110496227A (en) A clarified hydrophobic polyphenol delivery system based on oat β-glucan and its preparation method
CN116870171A (en) Oyster-source exosome-like vesicle and preparation method and application thereof
CN116509800A (en) Method and Application of Enhancing the Stability of Micron Calcium Carbonate Pickering Emulsion
CN114601170A (en) New method for dissolving heme
CN114431482A (en) Nano gel, preparation method and beverage reinforced by nano gel
CN105596377A (en) Cyclodextrin-Auricularia auricula micropowder combination and preparation method and preparation thereof
CN115606800B (en) Construction method of high-stability high-load glycosylated protein fiber nano delivery system
CN116268106B (en) Dairy product and preparation method thereof
CN107582524A (en) The preparation method of PluronicF87 curcumin liposomes
CN107865444A (en) A kind of preparation method of nanogel
CN119969566A (en) Preparation method of soybean protein isolate/κ-carrageenan composite gel loaded with VD3
CN118526471A (en) Double-targeting nanoparticle and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination